EUVIMEDEUVIMED entdecken
Crossref

DHX38 enhances proliferation, metastasis, and EMT progression in NSCLC through the G3BP1-mediated MAPK pathway

Ke Mi, Lizhong Zeng, Yang Chen, Jingya Ning, Siyuan Zhang, Peilin Zhao, Shuanying Yang

Cellular Signalling · 2024-01 · 113 · 110962

DOI: 10.1016/j.cellsig.2023.110962 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2024-01. Verfasst von Ke Mi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Xi’an Jiaotong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Non-small cell lung cancer (NSCLC) is a prevalent and aggressive malignancy with limited therapeutic options. Despite advances in treatment, NSCLC remains a major cause of cancer-related death worldwide. Tumor heterogeneity and therapy resistance present challenges in achieving remission. Research is needed to provide molecular insights, identify new targets, and develop personalized therapies to improve outcomes. METHODS: The protein expression level and prognostic value of DHX38 in NSCLC were explored in public databases and NSCLC tissue microarrays. DHX38 knockdown and overexpression cell lines were established to evaluate the role of DHX38 in NSCLC. In vitro and in vivo functional experiments were conducted to assess proliferation and metastasis. To determine the underlying molecular mechanism of DHX38 in human NSCLC, proteins that interact with DHX38 were isolated by IP and identified by LC-MS. KEGG analysis of DHX38-interacting proteins revealed the molecular pathway of DHX38 in human NSCLC. Abnormal pathway activation was verified by Western blot analysis and immunohistochemical (IHC) staining. A molecule-specific inhibitor was further used to explore potential therapeutic targets for NSCLC. The pathway-related target that interacted with DHX38 was verified by co-immunoprecipitation(co-IP) experiments. In cell lines with stable DHX38 overexpression, the target protein was knocked down to explore its complementary effect on DHX38 overexpression-induced tumor promotion. RESULTS: The protein expression of DHX38 was increased in NSCLC, and patients with high DHX38 expression levels had a poor prognosis. In vitro and in vivo experiments showed that DHX38 promoted the proliferation, migration and invasion of human NSCLC cells. DHX38 overexpression caused abnormal activation of the MAPK pathway and promoted epithelial-mesenchymal transition (EMT) in tumours. SCH772984, a novel specific ERK1/2 inhibitor, significantly reduced the increases in cell proliferation, migration and invasion caused by DHX38 overexpression. The co-IP experiments confirmed that DHX38 interacted with the Ras GTPase-activating protein-binding protein G3BP1. DHX38 regulated the expression of G3BP1. Knocking down G3BP1 in cells with stable DHX38 overexpression prevented DHX38-induced tumor cell proliferation, migration and invasion. Silencing G3BP1 reversed the MAPK pathway activation and EMT induced by DHX38 overexpression. CONCLUSION: In NSCLC, DHX38 functions as a tumor promoter. DHX38 modulates G3BP1 expression, leading to the activation of the MAPK signaling pathway, thus promoting tumor cell proliferation, metastasis, and the progression of epithelial-mesenchymal transition (EMT) in non-small cell lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansDNA HelicasesEpithelial-Mesenchymal TransitionCell Line, TumorPoly-ADP-Ribose Binding ProteinsRNA Recognition Motif ProteinsRNA HelicasesCell ProliferationCell MovementGene Expression Regulation, NeoplasticRNA Splicing FactorsDEAD-box RNA Helicases

Stichwörter der Autor:innen

DHX38EMTG3BP1MAPKNSCLC

Substanzen

DNA HelicasesPoly-ADP-Ribose Binding ProteinsRNA Recognition Motif ProteinsRNA HelicasesDHX38 protein, humanRNA Splicing FactorsDEAD-box RNA HelicasesG3BP1 protein, human

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Electronic address: yangshuanying66@163.com.

Förderung

  • Xi’an Jiaotong University

Zitieren

APA

Mi, K., Zeng, L., Chen, Y., Ning, J., Zhang, S., Zhao, P., & Yang, S. (2024). DHX38 enhances proliferation, metastasis, and EMT progression in NSCLC through the G3BP1-mediated MAPK pathway. Cellular Signalling, 113, 110962. https://doi.org/10.1016/j.cellsig.2023.110962

Vancouver

Mi K, Zeng L, Chen Y, Ning J, Zhang S, Zhao P, et al. DHX38 enhances proliferation, metastasis, and EMT progression in NSCLC through the G3BP1-mediated MAPK pathway. Cellular Signalling. 2024;113:110962. doi:10.1016/j.cellsig.2023.110962

BibTeX
@article{Mi2024,
  author = {Mi, Ke and Zeng, Lizhong and Chen, Yang and Ning, Jingya and Zhang, Siyuan and Zhao, Peilin and Yang, Shuanying},
  title = {DHX38 enhances proliferation, metastasis, and EMT progression in NSCLC through the G3BP1-mediated MAPK pathway},
  journal = {Cellular Signalling},
  year = {2024},
  volume = {113},
  pages = {110962},
  doi = {10.1016/j.cellsig.2023.110962}
}
Kostenlos starten →